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It is estimated that half or more of sexually transmitted
infection (STI) care episodes in the South African formal health
sector are treated by private general practitioners (GPs).1 Poor-
quality STI care has been well documented in this setting and
has been the subject of some debate and policy responses.1-4 In
the Department of Health’s HIV/AIDS and STD Strategic Plan
for 2000 - 2005,5 the first objective for STI control is ensuring
effective syndromic management in the private sector.
However, intervening in the private GP sector to improve
management of diseases of public health importance is
complex. Particularly in poor areas, GPs are often solo
practitioners operating in a highly autonomous manner, even
though they may be networked with other GPs in local
practitioner associations. Moreover, the sector is facing many
pressures resulting from changes in the regulatory
environment (around dispensing, drug prices and certificates
of need), an over-saturated market and declining profit
margins. These challenges are not unique to South Africa6 and
call for a far greater understanding of private providers and
the influences on their practice. 
We report on a study of private practices using record
reviews to measure quality of care for patients with STIs. In
particular, the sample sizes achieved with such an approach
made an analysis of prediction of quality possible.  In the hard-
to-reach private sector, valid and reliable measures of STI
treatment quality, let alone predictors of this quality, are
difficult to achieve. Self-reported practice will overestimate
quality, and observations of provider-client interactions and
use of simulated or ‘mystery’ clients are costly if adequate
sample sizes are to be obtained to conduct stratified analyses.7,8
The latter two techniques may also be difficult to negotiate
with independent providers. 
Methods
As part of a project to improve the quality of STI care among
private GPs, we studied the records of GPs based in three
districts (referred to as D1, D2 and D3) in Gauteng. The 64 GPs
in D1 (N = 26) and D2 (N = 38) were the subject of a
multifaceted intervention centred on a continuing medical
education (CME) seminar series, while the GPs in D3 (N = 34)
formed a reference group. All three groups were organised into
local independent practitioner associations (IPAs) and all GPs
dispensed drugs from their practices. 
At the end of the intervention period we obtained consent
from 26 of 45 randomly selected GP practices (15 in each
district) to examine retrospectively records of patients
attending their practices for two 3-month periods, viz. 
January - March 2000 and 2002. Using practice registers and
with the assistance of practice receptionists we identified 1 194
records of patient visits fitting 3 STI syndromes – urethral
discharge (UD) in men, pelvic inflammatory disease (PID) in
women, and genital ulcers (GU) in both men and women.
Given the complexity of interpreting prescribing, we did not
extract data on women with vaginal discharge. Each GP
contributed a mean of 46 records (median 50, range 8 - 98).
Two of the 26 GPs were women.
While ensuring patient anonymity and confidentiality, data
were extracted on syndrome, drugs prescribed and medical aid
status of the clients. Drug combinations were categorised into
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effective and ineffective (the latter including partially effective
regimens), utilising national guidelines developed by the STI
Reference Centre, National Health Laboratory Service. We also
recorded practice-level variables, namely gender and year of
qualification of the GP and whether s/he had worked as a
sessional doctor in the public sector (where GPs would have
been exposed to syndromic management of STIs). 
We pooled all the 1 194 records and entered patient and
practice-level variables into a forward step-wise logistical
regression model in order to assess factors associated with
effective STI prescriptions. Also entered into the model were
STI diagnosis (UD, PID or GU) to control for syndrome mix,
and GP district and time period (2000 or 2002) to control for
area and secular effects associated with the intervention. The
before and after analyses assessing the effectiveness of the
intervention are reported elsewhere,9 although trends over time
(between 2000 and 2002) for 2 syndromes (UD, PID) by
explanatory factor are provided. A chi-squared test was
performed on changes by sub-factor (e.g. medical aid status)
over the time period. Analysis was performed using the
Statistical Package for Social Sciences (SPSS). The project was
approved by the University of the Witwatersrand’s Committee
for Research on Human Subjects (Medical).
Results
The results of the logistical regression analysis are presented in
Table I. Records were more or less evenly distributed between
time periods and across districts. PID diagnoses constituted
nearly two-thirds of records and GU only 7.5%. More than half
the STI clients (53.4%) were cash paying. STI care was less than
optimal – depending on the syndrome, one-third or less of
drug combinations was judged effective. 
Characteristics significantly associated with effective drug
treatment (having controlled for syndrome, time period and
area) were as follows: (i) recent qualification – GPs who
qualified in the era of modern syndromic management (after
1993) were 3.5 times more likely to prescribe the correct
treatment than those who qualified before 1993 (p < 0.001); (ii)
client medical aid – STI clients with a medical aid were 2.64
times more likely to receive effective treatment than cash
clients (p < 0.001); and (iii) male gender of GP – although on bi-
variate analysis women GPs had slightly higher rates of
effective treatment, when controlling for other factors, male
GPs had double the odds of providing effective treatment 
(p = 0.007). 
Exposure to sessional work in the public sector did not
predict quality of prescribing.
Table I. Associations with effective drug combinations for STI syndrome and adjusted odds ratio after 
multivariate analysis (N = 1 194) 
N (% % effective Adjusted 95% CI of 
total sample) drug treatment odds ratio* adjusted odds ratio p-value
Insurance (medical aid) status (data
missing on 6 cases, N = 1 188)
Uninsured 634 (53.4) 16.6 2.64 1.95 - 3.58 < 0.001
Insured 554 (46.6) 31.4
GP gender
Female 149 (12.5) 26.1 2.13 1.23 - 3.68 0.007
Male 1 045 (87.5) 23.1
GP year of qualification
Before 1993 854 (71.5) 18.1 3.47 2.39 - 5.01 < 0.001
After 1993 340 (28.5) 36.8
Public-sector sessions
No 791 (66.2) 27.0 0.72 0.51 - 1.02 0.063
Yes 403 (33.8) 21.6
STI diagnosis
PID 787 (65.9) 22.5 1.00 - -
Urethral discharge 318 (26.6) 34.6 2.53 1.84 - 3.47 < 0.001
Genital ulcer 89 (7.5) 19.1 1.54 0.88 - 2.72 0.134
Area
District 3 303 (25.4) 20.5 1.00 - -
District 1 419 (35.1) 24.1 1.70 1.14 - 2.53 0.009
District 2 472 (39.5) 24.8 1.78 1.16 - 2.74 0.009
Period
2000 598 (50.1) 20.7 1.57 1.18 - 2.10 0.002
2002 596 (49.9) 26.2
*Reference category first.
CI = confidence interval; PID = pelvic inflammatory disease.
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There was an overall increase of effective scripts (from 20.7%
to 26.2%) between 2000 and 2002. When controlling for other
factors, GPs were 1.57 times more likely to prescribe
appropriate antibiotics for STIs in 2002 than in 2000. Of the
factors identified above, medical aid status emerged as the
most consistent predictor of treatment change in UD and PID,
the 2 syndromes where sample sizes allowed for analyses over
time (Table II). There was statistically significant improvement
in quality of prescribing for medical aid clients with UD 
(p < 0.001) and PID (p = 0.019) between 2000 and 2002, whereas
the quality of care for cash clients remained static.   Among
GPs, recent graduates showed higher baseline levels of
appropriate treatment than older graduates. They were also
more likely to change their treatment regimen for UD (p =
0.003) than older GPs (p = 0.039).
Discussion
There is variation in the quality of prescribing within the
private sector. Of the 4 factors measured, 3 emerged as
significantly associated with prescribing, namely year of
qualification and gender of the GP, and medical aid status of
the patient.
The generational differences in quality suggest that
undergraduate education effectively sets the patterns for future
practice. Alternatively, younger GPs may have less fixed
repertoires of prescribing, making them more receptive to new
knowledge received through CME than older GPs. 
Gender variation may reflect difficulties for women GPs in
balancing domestic roles with the need to update professional
knowledge. However, possible clustering effects from the small 
number of women GPs in the study may limit the ability to
draw firm conclusion on gender differences in quality. 
Client insurance status influenced quality of care,
independent of GP knowledge. There was selective
implementation of new knowledge in favour of medical aid
clients. For insured clients, the costs of drugs are recouped
from third-party payers, whereas cash clients pay an all-
inclusive fee that includes both the consultation and drugs. In
managing the latter, there is a financial incentive for GPs to
minimise costs by prescribing cheaper and less effective drugs. 
While methods to ensure greater access to updated
knowledge in the private sector is of key importance, it is our
view that without clear financial incentives the state has
limited leverage in ensuring quality private-sector treatment of
diseases of public health importance. Targeted subsidies (such
as provision of STI drugs for cash clients) to GPs in carefully
designed contracts may be one way not only to improve the
quality of STI care but to involve GPs more actively in the
district health system.
Finally, patient record systems were sufficiently developed in
GP practices to conduct record reviews; with the necessary
trust this may prove to be a viable form of routine quality
monitoring in the private health sector in South Africa.
However, doing this is premised on building trusting and co-
operative relationships between public and private sectors, a
situation that does not always obtain in South Africa.
This project was funded by a grant from the Wellcome Trust (Ref
no. 058607/Z/99/Z). We gratefully acknowledge the GPs and the
local health facilities and communities who participated in the
study.
Table II. Trends in quality of STI care for UD and PID between 2000 and 2002 by predictive factor (N = 1 105)
2000 2002
Effective Ineffective Effective Ineffective p-value
Factor Rx (%) Rx (%) Total Rx (%) Rx (%) Total (x2 test)
Urethral discharge
Medical aid 19 (28.4) 48 (71.6) 67 40 (58.0) 29 (42.0) 69 <0.001
Cash 27 (25.2) 80 (74.8) 107 23 (31.1) 51 (68.9) 74 0.243
Male GP 39 (25.2) 116 (74.8) 155 52 (40.0) 78 (60.0) 130 0.005
Female GP 8 (40.0) 12 (60.0) 20 11 (84.6) 2 (15.4) 13 0.013
Qualified 
before 1993 24 (19.0) 102 (81.0) 126 30 (30.0) 70 (70.0) 100 0.039
Qualified 
after 1993 23 (46.9) 26 (53.1) 49 33 (76.7) 10 (23.3) 43 0.003
Pelvic inflammatory disease
Medical aid 48 (22.6) 164 (77.4) 212 57 (32.6) 118 (67.4) 175 0.019
Cash client 16 (10.0) 144 (90.0) 160 29 (12.3) 207 (87.7) 236 0.296
Male GP 52 (16.5) 263 (83.5) 315 78 (21.9) 278 (78.1) 356 0.047
Female GP 12 (20.0) 48 (80.0) 60 8 (14.3) 48 (85.7) 56 0.286
Qualified 
before 1993 28 (11.0) 226 (89.0) 254 54 (17.6) 252 (82.4) 306 0.018
Qualified 
after 1993 36 (29.8) 85 (70.2) 121 32 (30.2) 74 (69.8) 106 0.529
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A view of paediatric outcomes research
Alan D Rothberg 
Costs of health care in the 21st century are on the increase.
Whether delivering previously unavailable primary care to
developing communities, treatment for resurgent malaria and
tuberculosis in Africa, antiretrovirals for rampant HIV in the
Third World, or newly developed technology and drugs to
treat diseases of lifestyle and degeneration in affluent societies,
health funding systems are having to decide on what is
affordable.  To make the necessary decisions one requires
health economic data in the form of cost-effectiveness and/or
cost-utility analyses.1 The former provide information on the
costs of achieving a clinical endpoint such as blood pressure
reduction, whereas the latter typically inform on the costs per
quality-adjusted life-year (QALY) gained.
By using QALYs one is able to assess clinical, economic and
humanistic outcomes, and convert the results into a value that
can be compared with other treatments for the same clinical
situation, or even with other conditions altogether (Figs 1 
and 2).  One can, for example, look at the QALYs gained as a
result of neonatal intensive care for 1 000 g babies and compare
these with QALYs gained through placement of drug-eluting
stents for the treatment of coronary artery disease, potentially
enabling decision makers to rank one above the other when it
comes to prioritisation of health care expenditure.  This all
sounds relatively simple and straightforward; however before
we can ask whether we can afford what we are doing it is
imperative that we know what we are actually achieving in
various clinical situations.
There is usually a far greater demand for health economic
information around complex, chronic and potentially costly
problems than is the case for simple, short-term, inexpensive
interventions, and one should therefore note that there are
some very real issues in paediatrics.  For example, and as
shown in Figs 1 and 2, real costs in paediatrics extend way
beyond the patient.  Parents are involved to a greater or lesser
extent, and depending on the chronicity and severity of the
child’s problem, employers may be affected through lost time
and productivity.  There may also be costs to society for
institutional care and/or lost productivity on the part of the
Intervention Use of health
care resources
Change in health status Change in productivity
Quality of life 
Patient satisfaction
Clinical outcomes
Economic outcomes
Fig. 1. Measuring value in health care.
Direct costs
Medical Non-medical
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Doctors etc. 
Drugs 
Pathology tests
Supplies Diagnostics
Transportation
Accomodation
Family care
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Pain 
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*Apply to patient and parents
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Fig. 2. Economic parameters in cost utility analyses.
School of Therapeutic Sciences, University of the Witwatersrand, Johannesburg
Alan D Rothberg, MB BCh, FCPaed, PhD
Corresponding author: Alan D Rothberg (rothbergd@therapy.wits.ac.za)
Pg 782-788 TIB  10/4/05  10:57 AM  Page 785
